|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/1774 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 31/12 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| A61P 31/12 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Patento numeris | 3721888 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20163565.3 |
| Europos patento paraiškos padavimo data | 2014-02-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-10-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361761133 P | 2013-02-05 | US |
| (72) |
WEISKOPF, Kipp , US
HASENKRUG, Kim J. , US
STODDART, Cheryl A. , US
MCCUNE, Joseph M. , US
WEISSMAN, Irving L. , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
The United States of America, as represented by the Secretary, Department of Health and Human Services , 6011 Executive Boulevard, Suite 325, MSC 7660, Bethesda, MD 20892-7660, US THE REGENTS OF THE UNIVERSITY OF CALIFORNIA , 1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200, US |
| (54) | CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE |
| CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE |